Pharmaceutical Companies Pay Billions of Dollars to Influence Medical Journal Reviewers
More than half of peer reviewers for four of the top medical journals received $1.06 billion in payments from the pharmaceutical industry during 2020-2022 alone, according to a research letter published in the Journal of the American Medical Association (JAMA). The payments went to peer reviewers for four of the leading scientific journals—JAMA, the British […]
Pharma Influences Diagnoses and Treatments in “Bible” of Psychiatric Disorders
A new study published in the British Medical Journal (BMJ) found that 55 of the 92 American doctors who determine what diagnoses and treatments are included in the American Psychiatric Association’s (APA) most recent edition of their Diagnostic and Statistical Manual (DSM) collectively received more than $14 million in previously undisclosed industry funding.1 The APA’s […]
Most Authors of Psychopharmacology Textbooks Have Financial Conflicts of Interest
A 2022 study published in Community Mental Health Journal examined nine commonly used psychopharmacology textbooks to identify financial conflicts of interest of their authors and editors. The findings showed that two-thirds of psychopharmacology textbooks authors or editors received personal financial payments from pharmaceutical companies. Unlike most medical journals that require authors to disclose their financial […]
